RCMI Coordinating Center (RCMI CC) Header Logo

Tayo A Adekiya, PhD

Title
InstitutionHoward University
Address2400 Sixth St NW
Washington DC 20059
ORCID ORCID Icon0000-0002-3382-9080 Additional info
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Adekiya TA, Hudson T, Bakare O, Ameyaw EE, Adebayo A, Olajubutu O, Adesina SK. PSMA-targeted combination brusatol and docetaxel nanotherapeutics for the treatment of prostate cancer. Biomed Pharmacother. 2024 Aug; 177:117125. PMID: 39002444.
      Citations:    Fields:    Translation:HumansAnimalsCells
    2. Adekiya TA, Moore M, Thomas M, Lake G, Hudson T, Adesina SK. Preparation, Optimization, and In-Vitro Evaluation of Brusatol- and Docetaxel-Loaded Nanoparticles for the Treatment of Prostate Cancer. Pharmaceutics. 2024 Jan 16; 16(1). PMID: 38258124.
      Citations:    
    3. Bataille Backer P, Adekiya TA, Kim Y, Reid TR, Thomas M, Adesina SK. Development of a Targeted SN-38-Conjugate for the Treatment of Glioblastoma. ACS Omega. 2024 Jan 16; 9(2):2615-2628. PMID: 38250376.
      Citations:    
    4. Adekiya TA, Owoseni O. Emerging frontiers in nanomedicine targeted therapy for prostate cancer. Cancer Treat Res Commun. 2023; 37:100778. PMID: 37992539.
      Citations:    Fields:    Translation:Humans
    5. Omoboyede V, Onile OS, Oyeyemi BF, Aruleba RT, Fadahunsi AI, Oke GA, Onile TA, Ibrahim O, Adekiya TA. Unravelling the anti-inflammatory mechanism of Allium cepa: an integration of network pharmacology and molecular docking approaches. Mol Divers. 2024 Apr; 28(2):727-747. PMID: 36867320.
      Citations: 2     Fields:    Translation:HumansAnimalsCells
    6. Oke SI, Ekum MI, Akintande OJ, Adeniyi MO, Adekiya TA, Achadu OJ, Matadi MB, Iyiola OS, Salawu SO. Optimal control of the coronavirus pandemic with both pharmaceutical and non-pharmaceutical interventions. Int J Dyn Control. 2023 Feb 01; 1-25. PMID: 36743263.
      Citations:    
    7. Adekiya TA, Kumar P, Kondiah PPD, Ubanako P, Choonara YE. In Vivo Evaluation of Praziquantel-Loaded Solid Lipid Nanoparticles against S. mansoni Infection in Preclinical Murine Models. Int J Mol Sci. 2022 Aug 22; 23(16). PMID: 36012770.
      Citations: 3     Fields:    Translation:Animals
    8. Adekiya TA, Kumar P, Kondiah PPD, Choonara YE. In Vivo Evaluation of an Antibody-Functionalized Lipoidal Nanosystem for Schistosomiasis Intervention. Pharmaceutics. 2022 Jul 22; 14(8). PMID: 35893786.
      Citations:    
    9. Aruleba RT, Adekiya TA, Ayawei N, Obaido G, Aruleba K, Mienye ID, Aruleba I, Ogbuokiri B. COVID-19 Diagnosis: A Review of Rapid Antigen, RT-PCR and Artificial Intelligence Methods. Bioengineering (Basel). 2022 Apr 03; 9(4). PMID: 35447713.
      Citations:    
    10. Adeola HA, Bello IO, Aruleba RT, Francisco NM, Adekiya TA, Adefuye AO, Ikwegbue PC, Musaigwa F. The Practicality of the Use of Liquid Biopsy in Early Diagnosis and Treatment Monitoring of Oral Cancer in Resource-Limited Settings. Cancers (Basel). 2022 Feb 23; 14(5). PMID: 35267452.
      Citations:    
    11. Adekiya TA, Kumar P, Kondiah PPD, Pillay V, Choonara YE. Synthesis and therapeutic delivery approaches for praziquantel: a patent review (2010-present). Expert Opin Ther Pat. 2021 Sep; 31(9):851-865. PMID: 33832392.
      Citations: 2     Fields:    Translation:HumansAnimals
    12. Adekiya TA, Aruleba RT, Klein A, Fadaka AO. In silico inhibition of SGTP4 as a therapeutic target for the treatment of schistosomiasis. J Biomol Struct Dyn. 2022 05; 40(8):3697-3705. PMID: 33225839.
      Citations: 7     Fields:    Translation:HumansAnimals
    13. Aruleba K, Obaido G, Ogbuokiri B, Fadaka AO, Klein A, Adekiya TA, Aruleba RT. Applications of Computational Methods in Biomedical Breast Cancer Imaging Diagnostics: A Review. J Imaging. 2020 Oct 08; 6(10). PMID: 34460546.
      Citations:    
    14. Adeola HA, Sabiu S, Adekiya TA, Aruleba RT, Aruwa CE, Oyinloye BE. Prospects of nanodentistry for the diagnosis and treatment of maxillofacial pathologies and cancers. Heliyon. 2020 Sep; 6(9):e04890. PMID: 32984600.
      Citations:    
    15. Ojo OA, Aruleba RT, Adekiya TA, Sibuyi NRS, Ojo AB, Ajiboye BO, Oyinloye BE, Adeola HA, Fadaka AO. Deciphering the interaction of puerarin with cancer macromolecules: An in silico investigation. J Biomol Struct Dyn. 2022 02; 40(2):848-859. PMID: 32924840.
      Citations: 10     Fields:    Translation:Humans
    16. Adekiya TA, Kondiah PPD, Choonara YE, Kumar P, Pillay V. A Review of Nanotechnology for Targeted Anti-schistosomal Therapy. Front Bioeng Biotechnol. 2020; 8:32. PMID: 32083071.
      Citations:    
    17. Adekiya TA, Aruleba RT, Oyinloye BE, Okosun KO, Kappo AP. The Effect of Climate Change and the Snail-Schistosome Cycle in Transmission and Bio-Control of Schistosomiasis in Sub-Saharan Africa. Int J Environ Res Public Health. 2019 12 26; 17(1). PMID: 31887979.
      Citations: 23     Fields:    Translation:HumansAnimalsPHPublic Health
    18. Ojo OA, Afon AA, Ojo AB, Ajiboye BO, Okesola MA, Aruleba RT, Adekiya TA, Oyinloye BE. Spondias mombim L. (Anacardiaceae): Chemical fingerprints, inhibitory activities, and molecular docking on key enzymes relevant to erectile dysfunction and Alzheimer's diseases. J Food Biochem. 2019 03; 43(3):e12772. PMID: 31353540.
      Citations: 3     Fields:    Translation:HumansAnimals
    19. Aruleba RT, Adekiya TA, Oyinloye BE, Masamba P, Mbatha LS, Pretorius A, Kappo AP. PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs? Infect Disord Drug Targets. 2019; 19(4):337-349. PMID: 30599112.
      Citations: 12     Fields:    Translation:HumansAnimals
    20. Oyinloye BE, Adekiya TA, Aruleba RT, Ojo OA, Ajiboye BO. Structure-Based Docking Studies of GLUT4 Towards Exploring Selected Phytochemicals from Solanum xanthocarpum as a Therapeutic Target for the Treatment of Cancer. Curr Drug Discov Technol. 2019; 16(4):406-416. PMID: 30068281.
      Citations: 6     Fields:    Translation:Animals
    21. Aruleba RT, Adekiya TA, Oyinloye BE, Kappo AP. Structural Studies of Predicted Ligand Binding Sites and Molecular Docking Analysis of Slc2a4 as a Therapeutic Target for the Treatment of Cancer. Int J Mol Sci. 2018 Jan 28; 19(2). PMID: 29382080.
      Citations: 18     Fields:    Translation:HumansCells
    22. Adekiya TA, Aruleba RT, Khanyile S, Masamba P, Oyinloye BE, Kappo AP. Structural Analysis and Epitope Prediction of MHC Class-1-Chain Related Protein-A for Cancer Vaccine Development. Vaccines (Basel). 2017 Dec 25; 6(1). PMID: 29295563.
      Citations:    
    Adekiya's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (69)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support